Durable responses upon short-term addition of targeted therapy to anti-PD1 in advanced melanoma patients: 5-year progression-free and overall survival update of the IMPemBra trial
Titel:
Durable responses upon short-term addition of targeted therapy to anti-PD1 in advanced melanoma patients: 5-year progression-free and overall survival update of the IMPemBra trial
Auteur:
Hoeijmakers, L.L. Rozeman, E.A. Lopez-Yurda, M. Grijpink-Ongering, L.G. Heeres, B.C. van de Wiel, B.A. Flohil, C. Sari, A. Heijmink, S.W.T.P.J. van den Broek, D. Broeks, A. de Groot, J.W.B. Vollebergh, M.A. Wilgenhof, S. van Thienen, J.V. Haanen, J.B.A.G. Blank, C.U.